Previous Article | Next Article 
Journal of Virology, April 2001, p. 3626-3635, Vol. 75, No. 8
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3626-3635.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Characterization of Intracellular Reverse
Transcription Complexes of Human Immunodeficiency Virus Type
1
Ariberto
Fassati1,2 and
Stephen P.
Goff1,*
Department of Biochemistry and Molecular
Biophysics, Howard Hughes Medical Institute, Columbia University
College of Physicians and Surgeons, New York, New York
10032,1 and Wohl Virion Centre, Windeyer
Institute, University College London, London W1P 6BD, United
Kingdom2
Received 9 June 2000/Accepted 23 January 2001
 |
ABSTRACT |
To examine the early events of the life cycle of human
immunodeficiency virus type 1 (HIV-1), we analyzed the intracellular complexes mediating reverse transcription isolated from acutely infected cells. Partial purification of the reverse transcription complexes (RTCs) by equilibrium density fractionation and velocity sedimentation indicated that two species of RTCs are formed but only
one species is able to synthesize DNA. Most of the capsid, matrix, and
reverse transcriptase (RT) proteins dissociate from the complex soon
after cell infection, but Vpr remains associated with the RTC. The RTCs
isolated 1, 4, and 7 h after infection are competent for reverse
transcription in vitro, indicating that a small proportion of RT
remains associated with them. HIV RTCs isolated early after infection
have a sedimentation velocity of approximately 560S. Later, different
species with a sedimentation velocity ranging from 350S to 100S appear.
Nuclear-associated RTCs have a sedimentation velocity of 80S. Shortly
after initiation of reverse transcription, the viral strong-stop DNA
within the RTC is sensitive to nuclease digestion and becomes protected
when reverse transcription is almost completed.
 |
INTRODUCTION |
All retroviruses copy the RNA genome
to form a double-stranded DNA molecule that is subsequently integrated
into the host chromosomal DNA. The process is catalyzed by reverse
transcriptase (RT) protein and is mainly carried out in the cytoplasm
soon after viral penetration into the cell (30). Reverse
transcription of the viral RNA genome into DNA is generally completed
in 8 to 12 h. We have recently characterized the Moloney murine
leukemia virus (MoMLV) intracellular viral complex mediating reverse
transcription and found that at least three distinct species of reverse
transcription complexes (RTCs) are formed shortly after acute infection
(7). Only one of these species is able to start and
complete reverse transcription. This RTC contains at least the viral
genome, p30 capsid (CA), integrase (IN), and RT proteins, and its
sedimentation velocity decreases with time, suggesting that a stepwise
uncoating process may occur during reverse transcription.
Little is known about the structure and composition of the human
immunodeficiency virus type 1 (HIV-1) RTC, particularly during the
early steps after virus internalization. Electron microscopic studies
showed that HIV cores are disrupted shortly after virus-cell fusion, in
contrast to MLV cores, which persist longer (15, 27). The
viral RNA and associated proteins are then released into the cytoplasm
and are likely to interact with the cytoskeleton (1). At
later stages of the viral life cycle, the fully reverse transcribed
HIV-1 DNA appears to be associated with RT, IN, and a subset of
phosphorylated matrix (MA) but only very weakly with p24 CA proteins
(4, 6, 18, 23). Specific cellular proteins have also
been found to associate with the viral DNA, including those
increasing the efficiency of integration of the viral genome in vitro
(5) and others preventing self-integration of the viral
DNA which would result in an nonproductive infection (19).
HIV, unlike MLVs, can infect nondividing cells (20, 28).
This ability depends on the active nuclear transport of its genome into
the nucleus of infected cells (2). Although a variety of
models have been proposed (3, 12, 13, 17, 32, 35), there
is no consensus on the precise mechanisms regulating nuclear import of
HIV (9, 11). Interactions between the intracellular viral
complexes mediating reverse transcription and karyopherins or the
nuclear pore complex may play a role (10, 13, 17, 26, 32).
A better characterization of the organization of HIV RTC may advance
understanding of the early interactions between virus and infected
cells as well as the mechanisms regulating HIV-1 infection of
nondividing cells. To examine the dynamics of the early events in the
HIV-1 life cycle, we have analyzed detergent-free cytoplasmic and
nuclear extracts at various time points after acute infection and
characterized the RTCs by equilibrium density fractionation and
velocity sedimentation.
 |
MATERIALS AND METHODS |
Cells and viruses.
293T and HeLa cells were grown in
Dulbecco's modified Eagle's medium supplemented with 2 mM glutamine
and 10% fetal calf serum at 37°C in an atmosphere containing 5%
CO2. To make replication-incompetent HIV-1 vectors, 5 × 106 293T cells were seeded in 100-mm-diameter dishes and
transfected the following day by calcium phosphate with 20 µg of
plasmid pHR' (containing the green fluorescent protein cDNA), 15 µg
of plasmid pCMV
R9, and 5 µg of plasmid pMD.G (25) per
dish. Culture medium was replaced after 24 h, the virus-containing
supernatant was collected 48 h after transfection and filtered
through a 0.45-µm-pore-size filter. The filtered supernatant was
incubated at 37°C for 1 h in the presence of 70 U of DNase I
(Boehringer) per ml and 10 mM MgCl2. Virus was purified by
centrifugation through a 25 to 45% sucrose cushion at 23,000 rpm in a
Beckman SW28 rotor for 2 h at 4°C. The sucrose interphase containing
purified virions was diluted fivefold in Dulbecco's modified Eagle
medium containing 20 mM HEPES (pH 7.4) and frozen at
80°C. Viral
titers were determined by infecting HeLa cells with serial dilution of
virus containing supernatant in the presence of Polybrene (8 µg/ml).
Approximately 36 h after infection, cells were harvested in
phosphate-buffered saline (PBS) containing 10 mM EDTA and analysed by
fluorescence-activated cell sorting to detect green fluorescent protein expression.
Cell extracts.
Approximately 107 HeLa cells were
infected in 175-cm2 flasks with 30 ml of 1:1-diluted virus
stock (3 × 106 CFU/ml) in the presence of Polybrene
(8 µg/ml). Infected cells were rapidly cooled to 4°C and incubated
for 2 h to allow viral adhesion to the cell receptor but not viral
internalization. Cells were then incubated at 37°C for 1, 4, 7, and
16 h, washed once in PBS-0.5 mM EDTA, trypsinized, and washed
again with PBS. All subsequent manipulations were carried out at 4°C.
The pellet containing the infected cells was resuspended in 5 volumes
of hypotonic buffer (10 mM HEPES [pH 7.9], 1.5 mM MgCl2,
10 mM KCl, 5 mM dithiothreitol [DTT], 20 µg of aprotinin/ml, 2 µg
of leupeptin/ml) and centrifuged for 5 min at 5,000 rpm in an Eppendorf
centrifuge (model 5415C). The pellet was resupended in 3 volumes of
hypotonic buffer and incubated for 10 min. Cells were homogenized with
10 to 15 strokes in a Dounce homogenizer, and nuclei and unbroken cells
were pelleted by centrifugation at 3,300 × g for 15 min. The supernatant (called cytoplasmic extract) was clarified by
centrifugation at 7,500 × g for 20 min, and the pellet
was discarded. The nuclear pellet from the previous centrifugation was
resuspended in approximately 600 µl of isotonic buffer (10 mM Tris
HCl [pH 7.4], 160 mM KCl, 5 mM MgCl2, 1 mM DTT, 20 µg
of aprotinin/ml, 2 µg of leupeptin/ml) and homogenized in a
ball-bearing homogenizer. The homogenate was then centrifuged at
7,500 × g for 20 min, and the supernatant (called
nuclear extract) was collected. Nuclear and cytoplasmic extracts were
adjusted to 8% sucrose, snap-frozen in liquid N2, and
stored at
70°C.
Equilibrium density gradients.
Continuous linear sucrose
gradients (5 ml) were poured with a two-chamber Hoefer SG gradient
maker using 20% sucrose solution in hypotonic buffer and 70% sucrose
solution in D2O and kept on ice. The pH of D2O
was adjusted to 7.4 by dropwise addition of 10 mM NaOH. Gradients were
overlaid with 0.5 ml of cytoplasmic or nuclear extracts and centrifuged
at 35,000 rpm at 4°C for 20 h in a Beckman SW55 rotor. Gradients
were fractionated by puncturing the bottom of the tube and collecting
12 fractions. The density was calculated by weighing 100 µl of each fraction.
Sedimentation velocity gradients.
Continuous gradients were
poured as described above, using 5 and 20% sucrose solutions in 50 mM
sodium phosphate buffer (pH 7.4) containing 2 mM DTT, 20 µg of
aprotinin/ml, and 2 µg of leupeptin/ml. Approximately 150 µl of the
equilibrium density fraction containing the peak of the viral DNA was
diluted with 1.2 ml of hypotonic buffer, loaded onto a Centricon 50 concentrator (Amicon), and centrifuged at 4,000 × g
for 30 min at 4°C in a Sorvall centrifuge. The concentrate (50 µl)
was resuspended in 300 µl of 50 mM sodium phosphate buffer, loaded on
a 5 to 20% continuous sucrose gradient, and centrifuged at 23,000 rpm
for 1 h at 4°C in a Beckman SW55 rotor. Fractions (0.4 ml each)
were collected by puncturing the bottom of the tube, and the density
was measured by weighing 100 µl of each fraction. In some instances,
viral DNA in fractions was precipitated by adding 1.5 µg of glycogen,
sodium acetate to a final concentration of 300 mM, and 2.5 volumes of
100% ethanol. The S value was calculated by the method of McEwen
(22). Calibration of the system was performed by
independently running 35S-labeled poliovirus, intact MoMLV,
and naked viral DNA through identical sucrose gradients.
PCR.
PCR was performed in a final volume of 50 µl
containing 1× PCR buffer, 100 µM each deoxynucleoside triphosphate
(dNTP), 2.5 mM MgCl2, 5 U of Taq polymerase
(Perkin-Elmer), and 30 picomol of each primer. Primer sequences were as
follows (nucleotide positions according to Muesing et al. [24] are
given in parentheses): strong-stop forward primer,
5'-GGCTAACTAGGGAACCCACTG-3' (505 to 525); strong-stop reverse complementary primer, 5'-CTGCTAGAGATTTTCCACACTGAC-3'
(630 to 653); Pol forward primer, 5'-TTCTTCAGAGCAGACCAG-3'
(2151 to 2168); Pol reverse complementary primer,
5'-ACTTTTGGGCCATCCATT-3' (2656 to 2639); positive-strand
forward primer, 5'-ACAAGCTAGTACCAGTTGAGCCAGATAAG-3' (158 to
186); and positive-strand reverse complementary primer, 5'-GCCGTGCGCGCTTCAGCAAGC-3' (730 to 709). Aliguots of 5 µl
of the equilibrium density fractions or 1.5 µl of the sedimentation velocity fractions were used as template for the PCR. Cycle parameters were 94°C for 3 min (first cycle), 94°C for 1 min, 55°C for
30 s, and 68°C for 1 min (35 to 45 cycles), and one final
extension cycle at 68°C for 10 min. PCR products were resolved on a
1% agarose-2% NuSieve gel and visualized by ethidium bromide
staining. Quantitative PCR was performed in duplicate in the conditions
described above, using twofold serial dilutions of the DNA template and
HIV plasmid pHR' (from 1 pg to 1.9 fg). After 30 cycles, PCR bands
were quantified by the Kodak Digital Science 1D image analysis
software, and the linear region of the reaction was then selected to
calculate RTC copy number, assuming that 1 fg of a 7-kb plasmid DNA
corresponds to 1.3 × 102 molecules.
Antibodies and Western blotting.
Human antiserum against
HIV-1 was a gift from Johnson Mak, McFarlane Burnet Centre for Medical
Research, Melbourne, Victoria, Australia; a monoclonal antibody against
p24 (ABT 14001) was purchased from American Biotechnologies Inc;
monoclonal antibody 11G10E6 against HIV RT was a gift from D. Helland,
University of Bergen, Bergen, Norway (29); monoclonal
antibody 9C5 against HIV-1 matrix was a gift from Bridget Ferns,
University College London, London, United Kingdom (8).
Antiserum to HIV-1 Vpr (1-46; from Jeffrey Kopp) was obtained through
the AIDS Research and Reference Reagent Program, Division of AIDS,
National Institutes of Health. Recombinant HIV-1 p17 MA and p24 CA
(from S. Adams and G. Reid, respectively) were obtained from the
Centralised Facility for AIDS Reagent supported by European Union
program EVA (contract QLK2-CT-1 999-00609) and the UK Medical Research
Council. For Western blot analyses, 300 µl of each fraction from the
density equilibrium gradients was diluted in 1.2 ml of ice-cold 50 mM
sodium phosphate buffer (pH 7.4) in the presence of 2 µg of bovine
serum albumin (Sigma) per ml and 10% (vol/vol) trichloroacetic acid.
Fractions were incubated at
20°C for 16 h and centrifuged for 30 min at 4°C at maximum speed in an Eppendorf Microfuge. Pellets were
washed once in a solution of ice-cold 80% acetone in distilled
H2O and resuspended in 20 µl of sodium dodecyl sulfate
(SDS) loading buffer (0.5 M Tris HCl [pH 6.8], 1% SDS, 10%
glycerol, 0.1% bromophenol blue, 1 mM EDTA, 10 mM DTT, 20 µg of
aprotinin/ml 2 µg of leupeptin hemisulfate/ml, 10 µg of
phenylmethylsulfonyl fluoride). The pH was adjusted to ~ 7.0 by
addition of 1 µl of 1.5 M Tris-HCl (pH 8.8). Samples were boiled for
5 min and loaded on an SDS-12.5% polyacrylamide gel. After
polyacrylamide gel electrophoresis (PAGE), the proteins were
transferred to a polyvinylidene difluoride (PVDF) membrane (Bio-Rad,
Hercules, Calif.) and probed with the primary antibodies for 1 h at
room temperature. Horseradish Peroxidase-conjugated secondary
antibodies were used diluted 1:10,000 (anti-human; Boehringer) 1:3,000
(anti-mouse; Promega), and 1:10,000 (anti-rabbit; Jackson) in 10%
nonfat milk (Nestle, Solon, Ohio). Enhanced chemiluminescence (ECL-Plus; Amersham) was used to develop the blots as described by the
manufacturer. Autoradiography films were exposed for different periods
of time to ensure linearity of the signal.
Assays for reverse transcription.
RT activity was tested
with the oligo(dT)-poly(rA) assay as previously described (14,
31). Briefly, 10 µl of samples was added to 40 µl of RT
cocktail {60 mM Tris-HCl (pH 8.0), 180 mM KCl, 6 mM
MgCl2, 6 mM DTT, 0.12% Triton X-100, 6 µg of
oligo(dT)/ml, 12 µg of poly(rA)/ml, 0.05 mM
[
-P32]dTTP (800 Ci/mmol)} for 1 h at 37°C.
Samples were spotted onto DE-81 paper and washed three times with 2×
SSC (0.3 M NaCl plus 0.03 M sodium citrate). A PhosphorImager
(Molecular Dynamics, Sunnyvale, Calif.) was used to quantitate the
radioactivity incorporated. Endogenous reverse transcription reactions
were carried out in 60 µl of buffer (100 mM Tris-HCl [pH 8.1], 15 mM NaCl, 6 mM MgCl2, 1 mM DTT, 2 mM each dNTP). Fifteen
microliters from the density equilibrium fractions was added to the
buffer and incubated for 4 to 6 h at 37°C. The products of
reverse transcription were detected by PCR using 5 µl of the
endogenous reaction as template.
Nuclease treatments
All nuclease treatments were performed
in 25 µl isotonic buffer containing 1 mM DTT, 20 µg each of
aprotinin and leupeptin hemisulfate per 15 ml, U of S7 micrococcal
nuclease (Boehringer), and 2 mM CaCl2. Five microliters
from the equilibrium density fractions containing the peak of
retroviral DNA was added to the nuclease mixture, and samples were
incubated on ice. The reaction was stopped by addition of 4 mM EGTA and
kept on ice. Two aliquots of 5 µl each from the same reaction were
analyzed by semiquantitative PCR with strong-stop and positive-strand
primers. The nuclease sensitivity of the intact RTCs was compared with
that of naked viral DNA. Control digests of naked viral DNA were
carried out in the presence of 5-µl aliquots from equilibrium density
fractions containing cytoplasmic extracts from uninfected HeLa cells
and having the same density as the fractions containing the RTCs.
 |
RESULTS |
Extraction of the HIV-1 RTC from acutely infected
cells.
Previous reports suggested that the RTC formed by HIV-1
pseudotyped with vesicular stomatitis virus glycoprotein (VSV-G)
envelope can be extracted in mild conditions, in contrast to those
formed by wild-type HIV, which can be extracted only in
high-ionic-strength buffers (1). To prepare HIV RTCs from
acutely infected cells, we used a protocol developed for MoMLV,
which allowed the isolation of functionally active RTCs
(7). HeLa cells were infected with a recombinant HIV-1
pseudotyped with VSV-G envelope (25) at a multiplicity of
infection of 5. Infection was synchronized by preincubating the cells
for 2 h at 4°C to allow for virus binding to the receptor. After
culturing for various times, cells were trypsinized, washed, and lysed
by hypotonic breakage of the cell membrane and Dounce homogenization
(see Materials and Methods). The cell extracts were subjected to
equilibrium density sedimentation, and fractions were analyzed by PCR
and Western blotting. In cytoplasmic extracts, HIV-1 strong-stop DNA
could be detected as a discrete peak at a density of 1.34 g/ml, similar
to MoMLV strong-stop DNA (7) and consistent with the
density of a nucleoprotein complex (Fig. 1). This density did not
change significantly with time (Fig. 1
and Table 1). In nuclear extracts,
strong-stop DNA was detected also at lower densities though a peak was
consistently present at 1.34 g/ml (Fig. 1 and Table 1). This peak was
present even after the nuclei were washed in buffer containing 0.5%
NP-40 (not shown). The bulk of the p24 protein was detected by both a
monoclonal antibody and patient antisera in a discrete peak having a
density of 1.14 to 1.12 g/ml and were never found cosedimenting with
the viral strong-stop DNA (Fig. 2A).
Recombinant HIV p24 was used to test the sensitivity of the Western
blotting, and quantitative PCR was used to quantitate the amount of RTC
molecules present in the sample. The fraction showing the peak of viral DNA contained normally between 3 × 107 to 5 × 107 RTC molecules/ml (not shown). The limit of detection of
p24 by Western blot was approximately 24 pg, corresponding to 6 × 108 molecules (Fig. 2B). Thus, our system was sensitive
enough to detect 60 p24 molecules/RTC. This suggested that most CA
proteins were lost from the complex after entry into the cell
cytoplasm. The quantity of CA in this peak reached a maximum 4 h
postinfection. Neither the strong-stop DNA or CA proteins were detected
in equilibrium density gradients containing extracts from uninfected
cells (not shown). Equilibrium density fractions were analyzed by
Western blotting to detect the presence of MA, RT, and Vpr. The peak of MA was found to fractionate at a buoyant density of 1.14 g/ml at 4 and
16 h after acute infection, similar to that for CA (Fig. 3A and
C). Small amounts of MA were found at a
density of 1.26 g/ml 4 h after infection; however, MA
cosedimenting with viral DNA was not detectable (Fig. 3A). Recombinant
p17 MA was used to test the sensitivity of the Western blotting. As few
as 3.5 pg of p17 could be detected by Western blotting in the same
conditions as used to detect p17 in density fractions (Fig. 3B),
corresponding to 1.2 × 108 molecules. Thus, the
sensitivity of the system allowed visualization of fewer than 15 molecules p17/RTC. RT was also found in the light fractions 4 h
after acute infection (Fig. 3A). A discrete peak of Vpr was found
cosedimenting with the viral DNA at a density of approximately 1.34 g/ml 4 and 16 h after acute infection, suggesting that substantial
levels of Vpr remained associated with the RTC (Fig. 3A and C).

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 1.
PCR analyses of cytoplasmic (A) and nuclear (B) extracts
after equilibrium density fractionation using primers specific for the
strong-stop DNA (expected band size is 145 bp). HeLa cells were
infected with an HIV-1-based vector; cell extracts were prepared 1, 4, and 7 h postinfection, loaded on a 20 to 70% linear sucrose
gradient, and centrifuged at 4°C for 20 h at 35,000 rpm in a
Beckman SW55 rotor. After centrifugation, gradients were collected in
12 fractions and analyzed. Arrows indicate the direction of the
gradient from the lowest (top) to the highest (bottom) density. The
density of the fraction containing the peak of the viral DNA is
indicated for each time point. Lanes: MW, DNA molecular weight
standards; 1 to 12, fractions 1 to 12. The rapidly migrating bands are
PCR artifacts. Hirt viral DNA was used as positive control (+);
uninfected Hela cells served as a negative control ( ). nucl,
nuclear.
|
|

View larger version (61K):
[in this window]
[in a new window]
|
FIG. 2.
(A) Western blot analyses of equilibrium density
fractions containing cytoplasmic extracts collected 1, 4, 7, and
16 h postinfection. Following SDS-PAGE and protein transfer, the
PVDF membrane was probed with a monoclonal antibody against HIV p24
capsid protein. Lanes: 1 to 12, fractions 1 to 12 as in Fig. 1; +,
purified virus; , uninfected HeLa cells; M, molecular weight markers.
The arrow indicates the direction of the gradient from the lowest (top)
to the highest (bottom) density. (B) Testing of sensitivity of Western
blotting using recombinant p24. Following SDS-PAGE and protein
transfer, the PVDF membrane was probed with the same antibody as used
for panel A and for the same exposure time. Lanes 1 to 13 correspond to
twofold serial dilutions of recombinant p24 from 3.2 ng to 0.7 pg.
|
|

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 3.
(A and C) PCR and Western blot analyses of equilibrium
density fractions containing cytoplasmic extracts collected 4 (A) and
16 (C) h after acute infection. Fractions were subjected to PCR with
primers specific for the strong-stop DNA (expected size is 145 bp).
Lanes: M, DNA molecular weight standards; 1 to 12, fractions 1 to 12. Following SDS-PAGE and protein transfer, the PVDF membrane was probed
with a polyclonal antibody against Vpr and a monoclonal antibody
against MA and RT. Controls were purified HIV-1 (+) and conditioned
medium from untransfected 293T cells ( ). Arrows indicate the
direction of the gradient, from the lowest density (top) to the highest
density (bottom). Positions of molecular weight markers are indicated
in kilodaltons on the left. (B) Testing of sensitivity of Western
blotting using recombinant p17. Following SDS-PAGE and protein
transfer, the PVDF membrane was probed with the same antibody as used
for panel A and for the same exposure time. Lanes 1 to 12 correspond to
twofold serial dilutions of recombinant p17 from 8 ng to 3.5 pg.
|
|
Partially purified RTCs are able to synthesize DNA.
To
evaluate whether the fractions containing the strong-stop DNA also
contained elongated reverse transcription products, aliquots from the
same fractions were subjected to PCR using a forward primer located on
the 5' long terminal repeat U5 region and a reverse primer located in
the 5' untranslated region. These primers are specific for the viral
positive-strand DNA, a late reverse transcription product. As shown in
Fig. 4, the positive-strand DNA could be
detected 7 h after acute infection. Contamination of plasmid DNA
carried over from transfection was excluded by PCR amplification of the
Pol region in the same fractions. This region is missing in the vector
plasmid but is present in the packaging plasmid used to prepare
recombinant HIV (25). To test whether the complexes were
competent to carry out reverse transcription in vitro, we performed an
endogenous reverse transcription assay on 10-fold dilutions of the
equilibrium density fractions containing the peak of the strong-stop
DNA. Samples were incubated at 37°C in the presence or absence of
dNTPs, and aliquots from the reactions were subjected to PCR using
primers specific for the positive strand. As shown in Fig.
5, following incubation at 37°C,
complexes isolated 1, 4, and 7 h after acute infection were able
to synthesize the positive-strand DNA, and addition of exogenous dNTPs
increased the efficiency of the reaction. Thus, the complexes
sedimenting at 1.34 g/ml are competent for DNA synthesis in vitro.
Fractions containing CA and MA proteins but no viral DNA might have
contained the viral RNA genome that could not be detected by standard
PCR. Therefore an endogenous reverse transcription assay was performed on fractions from the density gradients containing the cytoplasmic extracts collected 1 and 4 h after infection. Only small amounts of
strong-stop DNA were detected in some of those fractions containing CA
and MA that scored negative in previous assays (not shown). These
results suggested that most of the complexes found at lower densities
were poorly competent for reverse transcription.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 4.
PCR analyses of equilibrium density fractions containing
cytoplasmic extracts collected 1, 4, and 7 h postinfection.
Selected fractions from the equilibrium density gradients shown in Fig.
1 were subjected to PCR using primers specific for the Gag-Pol region
(pol primers; expected band size is 500 bp) and for the positive
(+)-strand DNA (expected size is 600 bp). Fractions 2 and 3 (F2 and F3)
are the same as in Fig. 1. Serial dilutions of pCMV R9 plasmid DNA
were used as the internal standard for Pol PCR. Hirt DNA from
uninfected cells was used as negative control ( ). Plasmid pHR' and
Hirt DNA from infected cells were used as internal controls for the
(+)-strand PCR. MW, DNA molecular weight standards.
Low-molecular-weight bands are PCR artifacts.
|
|

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 5.
Endogenous reverse transcription assay of equilibrium
density fractions containing the peak of the viral DNA from cytoplasmic
extracts collected 1, 4, and 7 h postinfection. Samples diluted
1:10 were incubated for 6 h at 37°C in the presence (+) or
absence ( ) exogenous dNTPs and then subjected to PCR with primers
specific for the (+)-strand DNA (expected band size is 600 bp).
|
|
Sedimentation velocity of the RTC during reverse
transcription.
To determine whether there were changes in the size
or shape of the RTC with a buoyant density of 1.34 g/ml during reverse transcription, we subjected partially purified RTCs to velocity sedimentation through linear sucrose gradients. The equilibrium density
fractions containing the peak of the viral DNA were dialyzed and
concentrated using a Centricon filter. The concentrate was then
analyzed by sedimentation velocity, and the position of the viral DNA
in the gradients was detected by PCR. In the cytoplasmic extracts
obtained 1 h after acute infection, a peak of viral DNA with a
sedimentation velocity of 560S was found. At later time points,
strong-stop DNA was found in many fractions although we consistently
detected discrete peaks of viral DNA having sedimentation velocities of
220S and 80S to 100S (Fig. 6 and Table
2); the former species were often more
abundant than the latter. In the nuclear extracts, viral DNA was found
only in fractions with a sedimentation velocity of approximately 80S
(Fig. 6 and Table 2). These results suggest that protein-DNA complexes
with a range of sizes and/or shapes are found in the cytoplasm at
different times during reverse transcription. Such a range of
properties appears much less pronounced in the nuclear-associated
complexes.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of RTCs by sedimentation velocity. Cytoplasmic
extracts collected 1, 4, 7, and 16 h postinfection and nuclear
extracts collected 7 h postinfection were subjected to equilibrium
density centrifugation. The fractions containing the peak of the
retroviral DNA were further purified, concentrated using a Centricon
filter, and centrifuged through a 5 to 20% linear sucrose gradient for
1 h at 23,000 rpm in a Beckman SW55 rotor. Twelve fractions were
collected, and the viral DNA in each fraction was detected by PCR using
primers specific for the strong-stop DNA (expected band size is 145 bp). The rapidly migrating bands are PCR artifacts. The arrow indicates
the direction of the gradient. nucl, nuclear.
|
|
Sensitivity of the strong-stop DNA to micrococcal nuclease.
To
evaluate the accessibility of the HIV DNA ends within the RTC, we
assayed the sensitivity to micrococcal nuclease of the viral
strong-stop DNA at various time points after acute infection. The
equilibrium density fractions from cytoplasmic extracts containing the
peak of the viral DNA were treated with micrococcal nuclease, and the
reaction was stopped at the time point indicated in Fig. 7 by addition of EGTA. Nuclease-treated
samples were then analyzed by PCR with primers specific for the
strong-stop DNA. When naked viral DNA was treated with micrococcal
nuclease, the strong-stop DNA appeared to be very sensitive to nuclease
digestion. Strong-stop DNA was very sensitive to nuclease digestion in
the RTC prepared 1 h after acute infection. To compare HIV and
MoMLV, 1-h fractions containing the peak of MoMLV or HIV DNA were mixed
1:1, subjected to nuclease digestion, and analyzed by PCR as described
above. While MoMLV strong stop was protected from nuclease digestion, HIV strong stop was not (Fig. 7B). The sensitivity to micrococcal nuclease appeared to decrease in HIV RTCs isolated at later time points
(Fig. 7A).

View larger version (38K):
[in this window]
[in a new window]
|
FIG. 7.
Sensitivity of the viral strong-stop DNA within the RTC
to micrococcal nuclease digestion. (A) Equilibrium density fractions
containing the peak of the viral DNA from the cytoplasmic extracts
collected 1, 4, and 7 h postinfection were incubated on ice in the
presence of micrococcal nuclease and 2 mM CaCl2. The
reactions were stopped by addition of 4 mM EGTA at the indicated time
points and analyzed by PCR using primers specific for the strong-stop
DNA (expected band size is 145 bp). Naked viral DNA was incubated as
above in the presence of micrococcal nuclease and cytoplasmic extracts
from uninfected cells (Hirt HIV). (B) Equilibrium density fractions
containing the peak of HIV-1 and MoMLV DNAs were mixed 1:1 and
subjected to micrococcal nuclease digestion as above. The reaction was
analyzed by PCR using primers specific for HIV or MoMLV strong stop. To
ensure the linearity of amplification, the samples were subjected to
two independent amplification rounds, one of 30 and one of 40 cycles.
|
|
 |
DISCUSSION |
In this study, we have analyzed the RTC of HIV-1 extracted from
cells at times ranging from shortly after viral penetration to
completion of reverse transcription. Analyses of the cytoplasmic extracts indicated that the newly synthesized viral DNA sedimented at a
density of 1.34 g/ml, similar to that seen for MoMLV (7). In nuclear extracts, viral DNA was found also at lower densities. This
is consistent with the possibility that some RTCs remained associated
with the nuclear membrane since we did not use detergents to prepare
nuclear extracts. In contrast to MoMLV RTC, no p24 CA proteins were
found cosedimenting at high density with HIV-1 DNA. CA proteins were
instead found in fractions having a buoyant density of approximately
1.14 g/ml. Thus, it is likely that most CA proteins dissociate from HIV
RTC very early after infection, although we would have failed to detect
any CA if fewer than 60 p24 molecules/RTC were present. Previous
electron microscopic studies also indicated that the HIV core is
disrupted in the process of virus internalization, while MoMLV cores
persist longer inside the infected cells (15, 27). Most RT
molecules were also found in the low-density fractions, dissociated
from the viral DNA. However, some RT must have been retained within the
RTC since complexes isolated 1, 4, and 7 h after acute infection
were competent for DNA synthesis in vitro. It would be interesting to
understand how small amounts of RT are retained within the RTC. MA was
found cosedimenting with CA in the same low-density fractions. Previous studies showed that a subset of phosphorylated MA remains associated with the viral DNA in the preintegration complex (PIC) (2, 3, 4,
12). Our inability to detect MA in the high-density fractions
may be due to insufficient sensitivity of the system, although we could
detect as few as 15 molecules of p17/RTC (corresponding to about 1% of
the MA content of an intact virion), or to the inability of the
monoclonal antibody to recognize phosphorylated MA. Vpr was found
cosedimenting with the viral DNA, suggesting that it was part of the
RTC. This is consistent with reports showing the presence of Vpr in the
PIC (12, 16, 26).
RTCs with a buoyant density of 1.34 g/ml were competent for reverse
transcription, as indicated by the presence of the (+)-strand DNA in
complexes isolated 7 h after acute infection and by their ability
to synthesize DNA in vitro. Only small amounts of strong-stop DNA were
found in fractions with a density of 1.14 g/ml subjected to an
endogenous reverse transcription reaction. Those fractions contained
both p24 and MA proteins. The ratio of CA to strong-stop DNA was high
in the low-density fractions containing cytoplasmic extracts isolated 1 and 4 h after infection (not shown), indicating that low-density
complexes were poorly competent for reverse transcription in vitro.
Such complexes did not synthesize strong-stop DNA in vivo 4 h
after acute infection and are likely to be dead-end products.
RTC species with a density of 1.34 g/ml appeared to include a wide
range of sizes and/or shapes. Complexes isolated 1 h after infection had a sedimentation velocity of 560S, similar to that of
early MoMLV RTCs (7). At later stages, complexes with a sedimentation velocity ranging from 350S to between 80S and 100S were
observed. Such complexes are slower sedimenting and presumably smaller
than MoMLV RTCs isolated at the same time after acute infection,
perhaps because no p24 CA remained associated with the HIV RTC.
Nuclear-associated RTCs had a sedimentation velocity of approximately
80S, similar to the slow-sedimenting peak observed in cytoplasmic
extracts. HIV PICs can be transported actively into the nucleus of
nondividing cells, as opposed to MoMLV PICs (2, 21, 28).
The smaller size of the cytoplasmic HIV RTC may also play a role in its
transport into the nucleus of infected cells.
Another difference between HIV and MoMLV RTCs is the sensitivity of the
DNA ends to micrococcal nuclease digestion. While the strong-stop DNA
within MoMLV RTC isolated 1, 4, and 7 h after infection is almost
completely resistant to nuclease digestion (7), HIV
strong-stop DNA is as sensitive as naked DNA in early RTCs and its
sensitivity appears to decrease with time. After completion of DNA
synthesis, the DNA ends appear to form a large nucleoprotein complex
called the intasome (33, 34). Our data suggest that the
intasome may take longer to organize in HIV than in MoMLV.
It should be noted that in this study we used a recombinant HIV-1
pseudotyped with VSV-G. The mechanisms of recombinant virus entry into
cells are therefore different from those for the wild-type virus,
mediated by gp120 and CD4 coreceptor interaction. In agreement with
previous studies, HIV RTC pseudotyped with VSV-G could be extracted in
the absence of detergents (1), thus allowing study of its
structure and protein composition in more physiological conditions. In
future studies, it will be interesting to investigate which one of the
different RTC species described here is competent for nuclear entry and integration.
 |
ACKNOWLEDGMENTS |
We are grateful to Bridget Ferns, Dag Helland, and Johnson Mak
for antibodies and to Eran Bacharach, Paul Clapham, Guanxia Gao, and
Masha Orlova for advice and helpful discussions. We thank Robin Weiss
and Yasuhiro Takeuchi for critically reading the manuscript.
A.F. is a Wellcome Trust International Prize Research Fellow. S.P.G. is
an Investigator of the Howard Hughes Medical Institute.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry and Molecular Biophysics, Howard Hughes Medical Institute, Columbia University College of Physicians and Surgeons, 701 W. 168th
St., New York, NY 10032. Phone: (212) 305-3794. Fax: (212) 305-8692. E-mail: goff{at}cuccfa.ccc.columbia.edu.
 |
REFERENCES |
| 1.
|
Bukrinskaya, A.,
B. Brichacek,
A. Mann, and M. Stevenson.
1998.
Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton.
J. Exp. Med.
188:2113-2125[Abstract/Free Full Text].
|
| 2.
|
Bukrinsky, M. I.,
N. Sharova,
M. P. Dempsey,
T. L. Stanwick,
A. G. Bukrinkaya,
S. Haggerty, and M. Stevenson.
1992.
Active nuclear import of human immunodeficiency virus type 1 preintegration complexes.
Proc. Natl. Acad. Sci. USA
89:6580-6584[Abstract/Free Full Text].
|
| 3.
|
Bukrinsky, M. I.,
S. Haggerty,
M. I. Dempsey,
N. Sharova,
A. Adzhubel,
L. Spitz,
P. Lewis,
D. Goldfarb,
M. Emerman, and M. Stevenson.
1993.
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.
Nature
365:666-669[CrossRef][Medline].
|
| 4.
|
Bukrinsky, M. I.,
N. Sharova,
T. L. McDonald,
T. Pushkarskaya,
W. G. Tarpley, and M. Stevenson.
1993.
Association of integrase, matrix and reverse transcriptase antigens of human immunodeficiency virus type 1 with viral nucleic acids following acute infection.
Proc. Natl. Acad. Sci. USA.
90:6125-6129[Abstract/Free Full Text].
|
| 5.
|
Farnet, C. M., and F. D. Bushman.
1997.
HIV-1 cDNA integration: requirement of HMG I(Y) protein for function of preintegration complexes in vitro.
Cell
88:483-492[CrossRef][Medline].
|
| 6.
|
Farnet, C. M., and W. A. Haseltine.
1991.
Determination of viral proteins present in the human immunodeficiency virus type 1 preintegration complex.
J. Virol.
65:1910-1915[Abstract/Free Full Text].
|
| 7.
|
Fassati, A., and S. P. Goff.
1999.
Characterization of intracellular reverse transcription complexes of Moloney murine leukemia virus.
J. Virol.
73:8919-8925[Abstract/Free Full Text].
|
| 8.
|
Ferns, R. B.,
R. S. Tedder, and R. A. Weiss.
1987.
Characterization of monoclonal antibodies against the human immunodeficiency virus (HIV) gag products and their use in monitoring HIV isolate variation.
J. Gen. Virol.
68:1543-1551[Abstract/Free Full Text].
|
| 9.
|
Fouchier, R. A.,
B. E. Meyer,
J. H. Simon,
U. Fischer, and M. Malim.
1997.
HIV-1 infection of non-dividing cells: evidence that the N-terminal basic region of the viral matrix protein is important for Gag processing but not for post-entry nuclear import.
EMBO J.
16:4531-4539[CrossRef][Medline].
|
| 10.
|
Fouchier, R. A.,
B. E. Meyer,
J. H. M. Simon,
U. Fischer,
A. V. Albright,
F. Gonzalez-Scarano, and M. H. Malim.
1998.
Interaction of the human immunodeficiency virus type 1 Vpr protein with the nuclear pore complex.
J. Virol.
72:6004-6013[Abstract/Free Full Text]
|
| 11.
|
Freed, E. O.,
G. Englund, and M. Martin.
1995.
Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
J. Virol.
72:3949-3954.
|
| 12.
|
Gallay, P.,
S. Swingler,
J. Song,
F. Bushman, and D. Trono.
1995.
HIV nuclear import is governed by the phosphotyrosine-mediated binding of matrix to the core domain of integrase.
Cell
83:569-576[CrossRef][Medline].
|
| 13.
|
Gallay, P.,
T. Hope,
D. Chin, and D. Trono.
1997.
HIV-1 infection of nondividing cells through the recognition of integrase by the importin/karyopherin pathway.
Proc. Natl. Acad. Sci. USA
94:9825-9830[Abstract/Free Full Text].
|
| 14.
|
Goff, S. P.,
P. Traktman, and D. Baltimore.
1981.
Isolation and properties of Moloney murine leukemia virus mutants: use of a rapid assay for release of virion reverse transcriptase.
J. Virol.
38:239-248[Abstract/Free Full Text].
|
| 15.
|
Grewe, C.,
A. Beck, and H. R. Gelderblom.
1990.
HIV: early virus-cell interactions.
J. Acquir. Immune Defic. Syndr.
3:965-974.
|
| 16.
|
Heinzinger, N. K.,
M. I. Bukrinsky,
S. A. Haggerty,
A. M. Ragland,
V. Kewalramani,
A. Lee,
H. E. Gendelman,
L. Ratner,
M. Stevenson, and M. Emerman.
1994.
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localisation of viral nucleic acids in non-dividing host cells.
Proc. Natl. Acad. Sci. USA
91:7311-7315[Abstract/Free Full Text].
|
| 17.
|
Jenkins, Y.,
M. McEntee,
K. Weis, and W. Greene.
1998.
Characterization of HIV-1 Vpr nuclear import: analysis of signals and pathways.
J. Cell Biol.
143:875-885[Abstract/Free Full Text].
|
| 18.
|
Karageorgos, L.,
P. Li, and C. Burrell.
1993.
Characterization of HIV replication complexes early after cell-to-cell infection.
AIDs Res. Hum. Retroviruses.
9:817-823[Medline].
|
| 19.
|
Lee, M. S., and R. Craigie.
1998.
A previously unidentified host protein protects retroviral DNA from autointegration.
Proc. Natl. Acad. Sci. USA
95:1528-1533[Abstract/Free Full Text].
|
| 20.
|
Lewis, P.,
M. Hensel, and M. Emerman.
1992.
Human immunodeficiency virus infection of cells arrested in the cell cycle.
EMBO J.
11:3053-3058[Medline]
|
| 21.
|
Lewis, P., and M. Emerman.
1994.
Passage through mitosis is required for oncoretroviruses but not for the human immunodeficiency virus.
J. Virol.
68:510-516[Abstract/Free Full Text].
|
| 22.
|
McEwen, C. R.
1967.
Tables for estimating sedimentation through linear concentration gradients of sucrose solution.
Anal. Biochem.
20:114-149[CrossRef][Medline].
|
| 23.
|
Miller, M. D.,
C. M. Farnet, and F. D. Bushman.
1997.
Human immunodeficiency virus type 1 preintegration complexes: studies of organization and composition.
J. Virol.
71:5382-5390[Abstract/Free Full Text].
|
| 24.
|
Muesing, M. A.,
D. H. Smith,
C. D. Cabradilla,
C. V. Benton,
L. A. Lasky, and D. J. Capon.
1985.
Nucleic acid structure and expression of the human AIDS/lymphoadenopathy retrovirus.
Nature
313:450-458[CrossRef][Medline].
|
| 25.
|
Naldini, L.,
U. Blomer,
P. Gallay,
D. Ory,
R. Mulligan,
F. H. Gage,
I. M. Verma, and D. Trono.
1996.
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
Science
272:263-267[Abstract].
|
| 26.
|
Popov, S.,
M. Rexach,
L. Ratner,
G. Blobel, and M. Bukrinsky.
1998.
Viral protein R regulates docking of the HIV-1 preintegration complex to the nuclear pore complex.
J. Biol. Chem.
273:13347-13352[Abstract/Free Full Text].
|
| 27.
|
Risco, C.,
L. Menendez-Arias,
T. D. Copeland,
P. Pinto da Silva, and S. Oroszlan.
1995.
Intracellular transport of the murine leukemia virus during acute infection of NIH 3T3 cells: nuclear import of nucleocapsid protein and integrase.
J. Cell Sci.
108:3039-3050[Abstract].
|
| 28.
|
Roe, T.-Y.,
T. C. Reynolds,
G. Yu, and P. O. Brown.
1993.
Integration of murine leukemia virus DNA depends on mitosis.
EMBO J.
12:2099-2108[Medline].
|
| 29.
|
Szilvay, A. M.,
S. Nornes,
I. R. Olsen,
V. R. Prasad,
C. Endresen,
S. P. Goff, and D. E. Helland.
1992.
Epitope mapping of HIV-1 reverse transcriptase with monoclonal antibodies that inhibit polymerase and RNAse H activities.
J. Acquir. Immune Defic. Syndr.
5:647-657.
|
| 30.
|
Telesnitsky, A., and S. P. Goff.
1997.
Reverse transcriptase and the generation of retroviral DNA, p. 121-160.
In
J. M. Coffin, S. H. Hughes, and H. E. Varmus (ed.), Retroviruses. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 31.
|
Telesnitsky, A.,
S. Blain, and S. P. Goff.
1993.
Assays for retroviral reverse transcriptase.
Methods Enzymol
262:347-362.
|
| 32.
|
Vodicka, M. A.,
D. M. Koepp,
P. A. Silver, and M. Emerman.
1998.
HIV-1 Vpr interacts with the nuclear transport pathway to promote macrophage infection.
Genes Dev.
12:175-185[Abstract/Free Full Text].
|
| 33.
|
Wei, S. Q.,
K. Mizuuchi, and R. Craigie.
1997.
A large nucleoprotein assembly at the ends of the viral DNA mediates retroviral DNA integration.
EMBO J.
16:7511-7520[CrossRef][Medline].
|
| 34.
|
Wei, S. Q.,
K. Mizuuchi, and R. Craigie.
1998.
Footprints on the viral DNA ends in Moloney murine leukemia virus preintegration complexes reflect a specific association with integrase.
Proc. Natl. Acad. Sci. USA
95:10535-10540[Abstract/Free Full Text].
|
| 35.
|
Zennou, V.,
C. Petit,
D. Guetard,
U. Nerhbass,
L. Montagnier, and P. Charneau.
2000.
HIV-1 genome nuclear import is mediated by a central DNA flap.
Cell
101:173-185[CrossRef][Medline].
|
Journal of Virology, April 2001, p. 3626-3635, Vol. 75, No. 8
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.8.3626-3635.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Riviere, L., Darlix, J.-L., Cimarelli, A.
(2010). Analysis of the Viral Elements Required in the Nuclear Import of HIV-1 DNA. J. Virol.
84: 729-739
[Abstract]
[Full Text]
-
Krishnan, L., Matreyek, K. A., Oztop, I., Lee, K., Tipper, C. H., Li, X., Dar, M. J., KewalRamani, V. N., Engelman, A.
(2010). The Requirement for Cellular Transportin 3 (TNPO3 or TRN-SR2) during Infection Maps to Human Immunodeficiency Virus Type 1 Capsid and Not Integrase. J. Virol.
84: 397-406
[Abstract]
[Full Text]
-
Bergamaschi, A., David, A., Le Rouzic, E., Nisole, S., Barre-Sinoussi, F., Pancino, G.
(2009). The CDK Inhibitor p21Cip1/WAF1 Is Induced by Fc{gamma}R Activation and Restricts the Replication of Human Immunodeficiency Virus Type 1 and Related Primate Lentiviruses in Human Macrophages. J. Virol.
83: 12253-12265
[Abstract]
[Full Text]
-
Li, Y., Kar, A. K., Sodroski, J.
(2009). Target Cell Type-Dependent Modulation of Human Immunodeficiency Virus Type 1 Capsid Disassembly by Cyclophilin A. J. Virol.
83: 10951-10962
[Abstract]
[Full Text]
-
Yamashita, M., Emerman, M.
(2009). Cellular Restriction Targeting Viral Capsids Perturbs Human Immunodeficiency Virus Type 1 Infection of Nondividing Cells. J. Virol.
83: 9835-9843
[Abstract]
[Full Text]
-
Onafuwa-Nuga, A., Telesnitsky, A.
(2009). The Remarkable Frequency of Human Immunodeficiency Virus Type 1 Genetic Recombination. Microbiol. Mol. Biol. Rev.
73: 451-480
[Abstract]
[Full Text]
-
Qi, M., Yang, R., Aiken, C.
(2008). Cyclophilin A-Dependent Restriction of Human Immunodeficiency Virus Type 1 Capsid Mutants for Infection of Nondividing Cells. J. Virol.
82: 12001-12008
[Abstract]
[Full Text]
-
Readinger, J. A., Schiralli, G. M., Jiang, J.-K., Thomas, C. J., August, A., Henderson, A. J., Schwartzberg, P. L.
(2008). Selective targeting of ITK blocks multiple steps of HIV replication. Proc. Natl. Acad. Sci. USA
105: 6684-6689
[Abstract]
[Full Text]
-
Warrilow, D., Meredith, L., Davis, A., Burrell, C., Li, P., Harrich, D.
(2008). Cell Factors Stimulate Human Immunodeficiency Virus Type 1 Reverse Transcription In Vitro. J. Virol.
82: 1425-1437
[Abstract]
[Full Text]
-
Spidel, J. L., Wilson, C. B., Craven, R. C., Wills, J. W.
(2007). Genetic Studies of the {beta}-Hairpin Loop of Rous Sarcoma Virus Capsid Protein. J. Virol.
81: 1288-1296
[Abstract]
[Full Text]
-
Agarwal, S., Harada, J., Schreifels, J., Lech, P., Nikolai, B., Yamaguchi, T., Chanda, S. K., Somia, N. V.
(2006). Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection. Proc. Natl. Acad. Sci. USA
103: 15933-15938
[Abstract]
[Full Text]
-
Puglia, J., Wang, T., Smith-Snyder, C., Cote, M., Scher, M., Pelletier, J. N., John, S., Jonsson, C. B., Roth, M. J.
(2006). Revealing Domain Structure through Linker-Scanning Analysis of the Murine Leukemia Virus (MuLV) RNase H and MuLV and Human Immunodeficiency Virus Type 1 Integrase Proteins. J. Virol.
80: 9497-9510
[Abstract]
[Full Text]
-
Wilhelm, M., Wilhelm, F.-X.
(2006). Cooperation between Reverse Transcriptase and Integrase during Reverse Transcription and Formation of the Preintegrative Complex of Ty1.. Eukaryot Cell
5: 1760-1769
[Abstract]
[Full Text]
-
Yu, J. H., Schaffer, D. V.
(2006). High-Throughput, Library-Based Selection of a Murine Leukemia Virus Variant To Infect Nondividing Cells. J. Virol.
80: 8981-8988
[Abstract]
[Full Text]
-
Hamamoto, S., Nishitsuji, H., Amagasa, T., Kannagi, M., Masuda, T.
(2006). Identification of a Novel Human Immunodeficiency Virus Type 1 Integrase Interactor, Gemin2, That Facilitates Efficient Viral cDNA Synthesis In Vivo. J. Virol.
80: 5670-5677
[Abstract]
[Full Text]
-
Dismuke, D. J., Aiken, C.
(2006). Evidence for a Functional Link between Uncoating of the Human Immunodeficiency Virus Type 1 Core and Nuclear Import of the Viral Preintegration Complex. J. Virol.
80: 3712-3720
[Abstract]
[Full Text]
-
Stremlau, M., Perron, M., Lee, M., Li, Y., Song, B., Javanbakht, H., Diaz-Griffero, F., Anderson, D. J., Sundquist, W. I., Sodroski, J.
(2006). From the Cover: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5{alpha} restriction factor. Proc. Natl. Acad. Sci. USA
103: 5514-5519
[Abstract]
[Full Text]
-
Jarrosson-Wuilleme, L., Goujon, C., Bernaud, J., Rigal, D., Darlix, J.-L., Cimarelli, A.
(2006). Transduction of Nondividing Human Macrophages with Gammaretrovirus-Derived Vectors. J. Virol.
80: 1152-1159
[Abstract]
[Full Text]
-
Bruce, J. W., Bradley, K. A., Ahlquist, P., Young, J. A. T.
(2005). Isolation of Cell Lines That Show Novel, Murine Leukemia Virus-Specific Blocks to Early Steps of Retroviral Replication. J. Virol.
79: 12969-12978
[Abstract]
[Full Text]
-
Haffar, O., Dubrovsky, L., Lowe, R., Berro, R., Kashanchi, F., Godden, J., Vanpouille, C., Bajorath, J., Bukrinsky, M.
(2005). Oxadiazols: a New Class of Rationally Designed Anti-Human Immunodeficiency Virus Compounds Targeting the Nuclear Localization Signal of the Viral Matrix Protein. J. Virol.
79: 13028-13036
[Abstract]
[Full Text]
-
Lehmann-Che, J., Giron, M.-L., Delelis, O., Lochelt, M., Bittoun, P., Tobaly-Tapiero, J., de The, H., Saib, A.
(2005). Protease-Dependent Uncoating of a Complex Retrovirus. J. Virol.
79: 9244-9253
[Abstract]
[Full Text]
-
Eshaghi, M., Tan, W. S., Ong, S. T., Yusoff, K.
(2005). Purification and Characterization of Nipah Virus Nucleocapsid Protein Produced in Insect Cells. J. Clin. Microbiol.
43: 3172-3177
[Abstract]
[Full Text]
-
Smith, A. J., Meyer, P. R., Asthana, D., Ashman, M. R., Scott, W. A.
(2005). Intracellular Substrates for the Primer-Unblocking Reaction by Human Immunodeficiency Virus Type 1 Reverse Transcriptase: Detection and Quantitation in Extracts from Quiescent- and Activated-Lymphocyte Subpopulations. Antimicrob. Agents Chemother.
49: 1761-1769
[Abstract]
[Full Text]
-
Forshey, B. M., Shi, J., Aiken, C.
(2005). Structural Requirements for Recognition of the Human Immunodeficiency Virus Type 1 Core during Host Restriction in Owl Monkey Cells. J. Virol.
79: 869-875
[Abstract]
[Full Text]
-
Mulky, A., Sarafianos, S. G., Arnold, E., Wu, X., Kappes, J. C.
(2004). Subunit-Specific Analysis of the Human Immunodeficiency Virus Type 1 Reverse Transcriptase In Vivo. J. Virol.
78: 7089-7096
[Abstract]
[Full Text]
-
Yamashita, M., Emerman, M.
(2004). Capsid Is a Dominant Determinant of Retrovirus Infectivity in Nondividing Cells. J. Virol.
78: 5670-5678
[Abstract]
[Full Text]
-
Narayan, S., Young, J. A. T.
(2004). Reconstitution of retroviral fusion and uncoating in a cell-free system. Proc. Natl. Acad. Sci. USA
101: 7721-7726
[Abstract]
[Full Text]
-
Zhu, K., Dobard, C., Chow, S. A.
(2004). Requirement for Integrase during Reverse Transcription of Human Immunodeficiency Virus Type 1 and the Effect of Cysteine Mutations of Integrase on Its Interactions with Reverse Transcriptase. J. Virol.
78: 5045-5055
[Abstract]
[Full Text]
-
Hehl, E. A., Joshi, P., Kalpana, G. V., Prasad, V. R.
(2004). Interaction between Human Immunodeficiency Virus Type 1 Reverse Transcriptase and Integrase Proteins. J. Virol.
78: 5056-5067
[Abstract]
[Full Text]
-
Owens, C. M., Song, B., Perron, M. J., Yang, P. C., Stremlau, M., Sodroski, J.
(2004). Binding and Susceptibility to Postentry Restriction Factors in Monkey Cells Are Specified by Distinct Regions of the Human Immunodeficiency Virus Type 1 Capsid. J. Virol.
78: 5423-5437
[Abstract]
[Full Text]
-
Chang, F., Re, F., Sebastian, S., Sazer, S., Luban, J.
(2004). HIV-1 Vpr Induces Defects in Mitosis, Cytokinesis, Nuclear Structure, and Centrosomes. Mol. Biol. Cell
15: 1793-1801
[Abstract]
[Full Text]
-
Schmitz, C., Marchant, D., Neil, S. J. D., Aubin, K., Reuter, S., Dittmar, M. T., McKnight, A.
(2004). Lv2, a Novel Postentry Restriction, Is Mediated by both Capsid and Envelope. J. Virol.
78: 2006-2016
[Abstract]
[Full Text]
-
Tang, S., Murakami, T., Cheng, N., Steven, A. C., Freed, E. O., Levin, J. G.
(2003). Human Immunodeficiency Virus Type 1 N-Terminal Capsid Mutants Containing Cores with Abnormally High Levels of Capsid Protein and Virtually No Reverse Transcriptase. J. Virol.
77: 12592-12602
[Abstract]
[Full Text]
-
Nermut, M. V., Fassati, A.
(2003). Structural Analyses of Purified Human Immunodeficiency Virus Type 1 Intracellular Reverse Transcription Complexes. J. Virol.
77: 8196-8206
[Abstract]
[Full Text]
-
Onafuwa, A., An, W., Robson, N. D., Telesnitsky, A.
(2003). Human Immunodeficiency Virus Type 1 Genetic Recombination Is More Frequent Than That of Moloney Murine Leukemia Virus despite Similar Template Switching Rates. J. Virol.
77: 4577-4587
[Abstract]
[Full Text]
-
Lyonnais, S., Hounsou, C., Teulade-Fichou, M.-P., Jeusset, J., Cam, E. L., Mirambeau, G.
(2002). G-quartets assembly within a G-rich DNA flap. A possible event at the center of the HIV-1 genome. Nucleic Acids Res
30: 5276-5283
[Abstract]
[Full Text]
-
Dvorin, J. D., Bell, P., Maul, G. G., Yamashita, M., Emerman, M., Malim, M. H.
(2002). Reassessment of the Roles of Integrase and the Central DNA Flap in Human Immunodeficiency Virus Type 1 Nuclear Import. J. Virol.
76: 12087-12096
[Abstract]
[Full Text]
-
Suzuki, Y., Craigie, R.
(2002). Regulatory Mechanisms by Which Barrier-to-Autointegration Factor Blocks Autointegration and Stimulates Intermolecular Integration of Moloney Murine Leukemia Virus Preintegration Complexes. J. Virol.
76: 12376-12380
[Abstract]
[Full Text]
-
McDonald, D., Vodicka, M. A., Lucero, G., Svitkina, T. M., Borisy, G. G., Emerman, M., Hope, T. J.
(2002). Visualization of the intracellular behavior of HIV in living cells. JCB
159: 441-452
[Abstract]
[Full Text]
-
Yuan, B., Fassati, A., Yueh, A., Goff, S. P.
(2002). Characterization of Moloney Murine Leukemia Virus p12 Mutants Blocked during Early Events of Infection. J. Virol.
76: 10801-10810
[Abstract]
[Full Text]
-
Seamon, J. A., Jones, K. S., Miller, C., Roth, M. J.
(2002). Inserting a Nuclear Targeting Signal into a Replication-Competent Moloney Murine Leukemia Virus Affects Viral Export and Is Not Sufficient for Cell Cycle-Independent Infection. J. Virol.
76: 8475-8484
[Abstract]
[Full Text]
-
Serhan, F., Jourdan, N., Saleun, S., Moullier, P., Duisit, G.
(2002). Characterization of Producer Cell-Dependent Restriction of Murine Leukemia Virus Replication. J. Virol.
76: 6609-6617
[Abstract]
[Full Text]
-
Forshey, B. M., von Schwedler, U., Sundquist, W. I., Aiken, C.
(2002). Formation of a Human Immunodeficiency Virus Type 1 Core of Optimal Stability Is Crucial for Viral Replication. J. Virol.
76: 5667-5677
[Abstract]
[Full Text]